Feda H. Hamdan - Concepedia

Author

Feda H. Hamdan

Also Known As

F Hamdan, F. Hamdan, Fatma Mohammed Hamdan, Feda H Hamdan, Feda H. Hamdan, Feda Hamdan, Feda Hisham Moh’d Hamdan, Feda' H. Hamdan, Feda' Hisham Hamdan, Hamdan, Feda Hisham Moh'd

148

Publications

942

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Universitätsmedizin Göttingen Mayo Clinic in Florida Robert Bosch Hospital University of Göttingen

About

Feda H. Hamdan is an author at Mayo Clinic specializing in cell biology, medicine, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	386
2	Engineering	3	3	137
3	Natural Sciences	2	2	98
4	Biomolecular Engineering	1	1	18
5	Biostatistics	1	1	18

Feda H. Hamdan

Publications

861

Citations

H-Index

Page 1

	Year	Citations
Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis Mengfei Liu, Sheng Cao, Li He, Nature Communications	2021	108
DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network Feda H. Hamdan, Steven A. Johnsen Proceedings of the National Academy of Sciences EngineeringGene SignatureGeneticsCancer BiologyEpigenetics	2018	97
ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells Madhobi Sen, Xin Wang, Feda H. Hamdan, Clinical Epigenetics	2019	63
Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells Maria Wiese, Feda H. Hamdan, Klaudia Kubiak, Cell Death and Disease	2020	60
Characterization of a dual <scp>BET</scp>/<scp>HDAC</scp> inhibitor for treatment of pancreatic ductal adenocarcinoma Xin Zhang, Tim Zegar, Tim Weiser, International Journal of Cancer	2020	51
Long non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300/ELK1 complex Amaia Navarro‐Corcuera, Tejasav S. Sehrawat, Nidhi Jalan‐Sakrikar, Journal of Hepatology P300/elk1 ComplexNon-coding Rna Acta2-as1Signal TransductionNatural SciencesRna Biology	2021	50
Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-β Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis Sayed Obaidullah Aseem, Nidhi Jalan‐Sakrikar, Cheng Chi, Gastroenterology Lysine 9CholangiopathiesCholangiocyte BiologyEpigeneticsBiliary Disorder	2020	48
Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites Melanie S. Patzak, Vijayalakshmi Kari, Shilpa Patil, EBioMedicine	2019	41
BRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cells Sankari Nagarajan, Upasana Bedi, Anusha Budida, Nucleic Acids Research Src KinaseBet InhibitorsMammary Gland DevelopmentTumor BiologyTranscriptional Regulation	2016	36
The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells D. Schneider, Robert Lorenz Chua, Nicole Molitor, Clinical Epigenetics Tumor BiologyOncologyMedicineApoptosisCell Death	2019	32

Page 1